Hypoglycemia induced by long-acting somatostatin analogues in a patient with nonfunctional neuroendocrine tumor
Makaleler > Tam Makale · 2009
Yazarlar: I. T. Unek, Aygül ÇELTİK, S. Yener, T. Yavuzsen, A. Alacacioglu, S. Cokmert, I. Oztop, B. Demirkan, O. Dicle, O. Sagol, R. Bekis, U. Yilmaz
JOURNAL OF BUON, SCI Expanded İndekslerine Giren Dergi, Uluslararası, 2009, cilt 14, ss 135-138
Özet
Somatostatin and its long-acting analogues are effective in symptom control in patients with functional neuroendocrine tumors; they are also able to control tumor growth. Somatostatin analogues are safe and generally well tolerated. In some cases they may cause serious complications.